| Wearable cardioverter–defibrillator after myocardial infarction JE Olgin, MJ Pletcher, E Vittinghoff, J Wranicz, R Malik, DP Morin, ... New England Journal of Medicine 379 (13), 1205-1215, 2018 | 338 | 2018 |
| The state of the art: atrial fibrillation epidemiology, prevention, and treatment DP Morin, ML Bernard, C Madias, PA Rogers, S Thihalolipavan, ... Mayo Clinic Proceedings 91 (12), 1778-1810, 2016 | 258 | 2016 |
| Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart … B Gorenek, J Bax, G Boriani, SA Chen, N Dagres, TV Glotzer, JS Healey, ... Ep Europace 19 (9), 1556-1578, 2017 | 211 | 2017 |
| Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies AR Menezes, CJ Lavie, JJ DiNicolantonio, J O'Keefe, DP Morin, S Khatib, ... Mayo Clinic Proceedings 88 (4), 394-409, 2013 | 181 | 2013 |
| Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large-or small-vessel disease: the … RA Bernstein, H Kamel, CB Granger, JP Piccini, PP Sethi, JM Katz, ... Jama 325 (21), 2169-2177, 2021 | 175 | 2021 |
| Predicting persistent left ventricular dysfunction following myocardial infarction: the PREDICTS study GC Brooks, BK Lee, R Rao, F Lin, DP Morin, SL Zweibel, AE Buxton, ... Journal of the American College of Cardiology 67 (10), 1186-1196, 2016 | 112 | 2016 |
| European heart rhythm association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on … N Dagres, TF Chao, G Fenelon, L Aguinaga, D Benhayon, EJ Benjamin, ... EP Europace 20 (9), 1399-1421, 2018 | 104 | 2018 |
| Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction DP Morin, MN Saad, OF Shams, JS Owen, JQ Xue, FM Abi-Samra, ... Europace 14 (8), 1172-1179, 2012 | 92 | 2012 |
| Impact of wearable cardioverter‐defibrillator compliance on outcomes in the VEST trial: as‐treated and per‐protocol analyses JE Olgin, BK Lee, E Vittinghoff, DP Morin, S Zweibel, E Rashba, ... Journal of cardiovascular electrophysiology 31 (5), 1009-1018, 2020 | 86 | 2020 |
| QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study DP Morin, L Oikarinen, M Viitasalo, L Toivonen, MS Nieminen, ... European heart journal 30 (23), 2908-2914, 2009 | 86 | 2009 |
| Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction DJ Cantillon, KM Stein, SM Markowitz, S Mittal, BK Shah, DP Morin, ... Journal of the American College of Cardiology 50 (2), 166-173, 2007 | 78 | 2007 |
| T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy TM Rosenthal, PF Stahls III, FM Abi Samra, ML Bernard, S Khatib, ... Heart rhythm 12 (8), 1789-1797, 2015 | 77 | 2015 |
| Lifestyle modification in the prevention and treatment of atrial fibrillation AR Menezes, CJ Lavie, A De Schutter, RV Milani, J O’Keefe, ... Progress in cardiovascular diseases 58 (2), 117-125, 2015 | 76 | 2015 |
| Surface electrocardiogram predictors of sudden cardiac arrest SA Abdelghani, TM Rosenthal, DP Morin Ochsner Journal 16 (3), 280-289, 2016 | 75 | 2016 |
| Cardiac resynchronization therapy: history, present status, and future directions LM Jaffe, DP Morin Ochsner journal 14 (4), 596-607, 2014 | 75 | 2014 |
| Atrial fibrillation and heart failure: update 2015 S Thihalolipavan, DP Morin Progress in Cardiovascular Diseases 58 (2), 126-135, 2015 | 72 | 2015 |
| Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction RV Milani, MH Drazner, CJ Lavie, DP Morin, HO Ventura The American journal of cardiology 108 (7), 992-996, 2011 | 70 | 2011 |
| Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT) M Singh, DP Morin, MS Link Progress in cardiovascular diseases 62 (3), 227-234, 2019 | 65 | 2019 |
| Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention TM Rosenthal, D Masvidal, FM Abi Samra, ML Bernard, S Khatib, ... Ep Europace 20 (4), 698-705, 2018 | 54 | 2018 |
| Usefulness of precordial T-wave inversion to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia arising from the right … DP Morin, AC Mauer, K Gear, W Zareba, SM Markowitz, FI Marcus, ... The American journal of cardiology 105 (12), 1821-1824, 2010 | 45 | 2010 |
Carl LavieOchsner Clinical Schoolochsner.org üzerinde doğrulanmış e-posta adresine sahip